Td Asset Management Inc Ambrx Biopharma Inc. Transaction History

Td Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$9.3 - $16.6 $434,570 - $775,684	46,728 Added 73.32%	110,456 $1.27 Million
Q2 2023 Aug 09, 2023	BUY	$7.66 - $16.46 $381,682 - $820,168	49,828 Added 358.47%	63,728 $1.05 Million
Q1 2023 May 10, 2023	BUY	$1.46 - $12.54 $20,294 - $174,306	13,900 New	13,900 $123,000

31.2K

Ticker AMAM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,618,400
Market Cap $1.08B
Description
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.